Zepp Health Corp (ZEPP) reports a 6.9% revenue increase to $63.5 million, but guides Q3 lower due to supply bottlenecks and macroeconomic headwinds.
Zepp Health (NYSE:ZEPP) reported second-quarter 2026 revenue of $63.5 million, up 6.9% from a year earlier, as new product launches and a higher-priced product mix supported growth. Gross margin improved to 37.4% from 36.2% a year earlier despite higher memory and component costs, according to manag
Zepp Health Corporation (NYSE: ZEPP) ("Zepp", the "Company" or "we") today announced its unaudited financial results for the second quarter of 2026.
This is the newest page. Registered accounts read further back.